Clinical Trials Browser

Phase 2 × Biliary Tract Neoplasms × Panitumumab × Clear all

NCT00948935 2020-03-11

Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma

Phase 2 Completed

35 enrolled 7 charts

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma